Patent · US Active

Influenza vaccines

US12234263B2 · kind B2 · utility

0Cited by

35References

20Claims

0Family size

Assignees

InvVax, Inc. · US
The Regents of the University of California · US

Inventors

Arthur Young · Cypress, US
Ren Sun · Los Angeles, US
Nicholas Wu · Witchcliffe, AU

Key dates

Filing date	Jun 30, 2023
Grant date	Feb 25, 2025
Priority date	—
Expiry date	Jun 30, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16334
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compositions related to vaccines, e.g., influenza vaccines, including, peptide based vaccines, nucleic acid based vaccines, recombinant virus based vaccines, antibody based vaccines, and virus based vaccines. Also provided herein are methods related to vaccines, e.g., influenza vaccines, including methods of identifying epitopes for the vaccines, producing, formulating, and administering the vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.